Key result
High serum levels of C5, FGG, PKM2, and TPM4 were linked to severe coronary artery calcification, and their combination distinguished CAC from non-CAC patients with an AUC of 0.936.
Why the study?
Proteomic studies investigating novel molecular markers of coronary artery calcification are scarce.
Case-Control (n=160)
No
Effect estimate: AUC 0.936 (95% CI 0.869-0.975)
p-value: p=<0.001
High serum levels of C5, FGG, PKM2, and TPM4 are significantly associated with severe coronary artery calcification and may serve as diagnostic biomarkers.
These proteins merit prospective validation as CAC biomarkers; hypothesis-generating and should not yet change practice.
Background: Proteomic studies investigating novel molecular markers of coronary artery calcification (CAC) are scarce.This study compared the protein expression in the serum of patients with severe CAC and non-CAC. Methods: The serum from 30 patients with severe CAC and 30 matched-controls were screened by data-independent acquisition(DIA)-based proteomic technology. Bioinformatics analysis tools were used to analyze the underlying molecular mechanisms of the differentially expressed proteins. Candidate proteins were further validated by an enzyme-linked immunosorbent assay (ELISA) in an independent cohort. A receiver operating characteristic (ROC) curve was used to estimate the diagnostic power of the candidate proteins. Results: 0.05) between patients with and without CAC. Bioinformatics analysis indicated that the differential proteins are involved in complement and coagulation cascades, platelet activation, regulation of actin cytoskeleton, or glycolysis/gluconeogenesis pathways. Further verification showed that serum levels of complement C5 (C5), fibrinogen gamma (FGG), pyruvate kinase isoform M2 (PKM2), and tropomyosin 4 (TPM4) were consistent with the proteomic findings, which could allow discrimination between CAC and non-CAC patients. Conclusions: This study revealed that high serum levels of serum C5, FGG, PKM2, and TPM4 proteins were linked to severe CAC. These proteins may be developed as biomarkers to predict coronary calcification.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2022) conducted a case-control in Severe Coronary Artery Calcification (n=160). Severe Coronary Artery Calcification vs. Matched controls without coronary artery calcification was evaluated on Diagnostic accuracy (AUC) of combined serum C5, FGG, PKM2, and TPM4 for severe coronary artery calcification (AUC 0.936, 95% CI 0.869-0.975, p=<0.001). High serum levels of C5, FGG, PKM2, and TPM4 were linked to severe coronary artery calcification, and their combination distinguished CAC from non-CAC patients with an AUC of 0.936.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: